Valentina Cannone Selected Research

Valentina Cannone Research Topics

Disease

11	Hypertension (High Blood Pressure) 01/2022 - 04/2011
6	Heart Failure 06/2021 - 12/2011
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019 - 08/2011
5	Obesity 01/2017 - 08/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2013
4	Metabolic Diseases (Metabolic Disease) 07/2019 - 01/2015
2	Atherosclerosis 10/2019 - 09/2017
2	Chronic Renal Insufficiency 12/2015 - 01/2015
2	Abdominal Obesity 12/2015 - 01/2015
1	Renal Insufficiency (Renal Failure) 01/2022
1	Essential Hypertension 01/2021
1	Ascites 05/2020
1	Breast Neoplasms (Breast Cancer) 05/2020
1	Eclampsia 05/2020
1	Edema (Dropsy) 05/2020
1	Neoplasm Metastasis (Metastasis) 05/2020
1	Abdominal Pain (Pain, Abdominal) 05/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2020
1	Posterior Leukoencephalopathy Syndrome 05/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Inappropriate ADH Syndrome (SIADH) 01/2020
1	Headache (Headaches) 01/2020
1	Hyponatremia 01/2020
1	Hypocalcemia 01/2020
1	Hyperkalemia 01/2020
1	Neoplasms (Cancer) 01/2020
1	Fatigue 01/2020
1	Paraganglioma (Paragangliomas) 01/2020
1	Pheochromocytoma 01/2020
1	Polycythemia (Erythrocytosis) 01/2020
1	Proteinuria 01/2020
1	Hyperphosphatemia 01/2020
1	Tumor Lysis Syndrome 01/2020
1	Insulin Resistance 07/2019
1	Inflammation (Inflammations) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2015
1	Atrial Fibrillation 01/2015
1	Stroke (Strokes) 12/2011
1	Myocardial Infarction 08/2011

Drug/Important Bio-Agent (IBA)

10	Atrial Natriuretic Factor (ANF)IBA 12/2021 - 08/2011
5	AldosteroneIBA 01/2021 - 01/2015
4	Natriuretic PeptidesIBA 01/2021 - 10/2014
4	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2019 - 12/2011
3	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 12/2011
3	HDL CholesterolIBA 01/2017 - 08/2011
2	SodiumIBA 01/2022 - 01/2020
2	Vasopressins (Vasopressin)IBA 01/2022 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 04/2011
2	MagnesiumIBA 05/2020 - 01/2020
2	LipidsIBA 07/2019 - 12/2015
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 01/2015
1	Tolvaptan FDA Link 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2022
1	CreatinineIBA 01/2022
1	Hormones (Hormone)IBA 01/2021
1	atrial natriuretic factor receptor AIBA 01/2021
1	Estrogen Receptor AntagonistsIBA 05/2020
1	palbociclibIBA 05/2020
1	Bevacizumab (Avastin)FDA Link 05/2020
1	Fulvestrant (Faslodex)FDA Link 05/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	Chromogranin AIBA 01/2020
1	Erythropoietin FDA Link 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	PotassiumIBA 01/2020
1	EnzymesIBA 01/2020
1	ElectrolytesIBA 01/2020
1	CalciumIBA 01/2020
1	Vinca AlkaloidsIBA 01/2020
1	Alkylating AgentsIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Platinum Compounds (Compounds, Platinum)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	cenderitideIBA 01/2018
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2018
1	Cyclic GMPIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	HDL LipoproteinsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	C-Reactive ProteinIBA 08/2011

Therapy/Procedure

6	Therapeutics 06/2021 - 09/2013
2	Drug Therapy (Chemotherapy) 05/2020 - 01/2020
1	Genomic Medicine 01/2021
1	Radiotherapy 05/2020
1	Adrenalectomy 01/2020